Skip to results

Expected publication date

Expected publication date

Area of interest

Area of interest

Type (2 selected)

Type

Guidance programme

Advice programme

Showing 351 to 375 of 402

Guidance, NICE advice and quality standards in development
TitleTypeExpected publication date
Targeted Muscle Reinnervation for refractory pain after limb amputationInterventional procedures guidance
Tarlatamab for previously treated advanced small-cell lung cancer [ID6364]Technology appraisal guidance
Taselisib for previously treated ER-positive, HER2-negative, PIK3CA-positive breast cancer in postmenopausal women ID1401Technology appraisal guidanceTBC
Tebentafusp for treating advanced (unresectable or metastatic) uveal melanoma [ID1441]Technology appraisal guidanceTBC
Technologies for the assessment of attention deficit hyperactivity disorder (ADHD)Diagnostics guidance
Teclistamab for treating relapsed and refractory multiple myeloma after 3 or more treatments (Review of TA869) [ID6333]Technology appraisal guidanceTBC
Telisotuzumab vedotin for treating c-MET overexpressed, EGFR wild-type, non-squamous advanced non-small-cell lung cancer after 1 or more systemic treatments [ID6253]Technology appraisal guidanceTBC
Tenecteplase for treating acute ischaemic stroke [ID6306]Technology appraisal guidance
Teplizumab for delaying the onset of type 1 diabetes in people 8 years and over at risk of developing the condition ID6259Technology appraisal guidanceTBC
Teprotumumab for treating thyroid eye disease ID6432Technology appraisal guidanceTBC
Third molars (impacted) - prophylactic removal [ID898]Technology appraisal guidanceTBC
Tirzepatide for managing overweight and obesity [ID6179]Technology appraisal guidance
Tislelizumab for treating unresectable advanced oesophageal squamous cell cancer after platinum-based chemotherapy [ID4070]Technology appraisal guidanceTBC
Tisotumab vedotin for treating recurrent or metastatic cervical cancer after systemic therapy [ID3753]Technology appraisal guidanceTBC
Tobacco: preventing uptake, promoting quitting and treating dependence - Cytisine for smoking cessationNICE guidelineTBC
Topical Antimicrobial dressings for wound care: Late stage assessmentHealth technology evaluation
Topical rapamycin for treating facial angiofibromas associated with tuberous sclerosis complex in people 6 years and over [ID6391]Technology appraisal guidanceTBC
Total hip arthroplasty using the superpath approach for osteoarthritisInterventional procedures guidanceTBC
Tralokinumab for treating moderate to severe atopic dermatitis [ID3734]Technology appraisal guidanceTBC
Transcatheter aortic valve implantation for native aortic valve regurgitationInterventional procedures guidance
Transcatheter heart valves for transcatheter aortic valve implantation in people with aortic stenosis: Late stage assessmentHealth technology evaluation
Trastuzumab deruxtecan for treating HER2-low metastatic or unresectable breast cancer after chemotherapy [ID3935]Technology appraisal guidanceTBC
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 treatments [ID6309]Technology appraisal guidance
Treatments for non-small-cell lung cancer [ID6234]Technology appraisal guidanceTBC
Trifluridine–tipiracil with bevacizumab for treating metastatic colorectal cancer after 2 systemic treatments [ID6298]Technology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All